KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Shares Issued (2016 - 2025)

Precigen (PGEN) has disclosed Shares Issued for 14 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 361.24% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2025, down 96.15% year-over-year, with the annual reading at $1.2 million for FY2025, 96.15% down from the prior year.
  • Shares Issued for Q4 2025 was $1.6 million at Precigen, up from -$355000.0 in the prior quarter.
  • The five-year high for Shares Issued was $120.8 million in Q3 2021, with the low at -$693000.0 in Q2 2023.
  • Average Shares Issued over 5 years is $20.6 million, with a median of $111000.0 recorded in 2021.
  • The sharpest move saw Shares Issued skyrocketed 445.8% in 2021, then plummeted 69400.0% in 2023.
  • Over 5 years, Shares Issued stood at $120.8 million in 2021, then crashed by 100.0% to -$1000.0 in 2022, then crashed by 69200.0% to -$693000.0 in 2023, then rose by 14.0% to -$596000.0 in 2024, then skyrocketed by 361.24% to $1.6 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $1.6 million, -$355000.0, and -$596000.0 for Q4 2025, Q1 2025, and Q4 2024 respectively.